Halozyme Therapeutics (HALO) Asset Writedowns and Impairment (2019 - 2020)
Halozyme Therapeutics' Asset Writedowns and Impairment was $48.7 million in FY2025.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Asset Writedowns and Impairment (2019 - 2020) Analysis & Trends
- Asset Writedowns and Impairment shows a five-year compound annual growth rate of 142.8% (FY2020 to FY2025).
- The FY2025 figure marks the lowest annual Asset Writedowns and Impairment since FY2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Halozyme Therapeutics | 12.53 Bn | 11.13 Bn | 401.83 Mn |
API Access
Halozyme Therapeutics Asset Writedowns and Impairment API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-writedowns-and-impairment", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();